Results 271 to 280 of about 27,566 (317)
Some of the next articles are maybe not open access.
Advances in Materials, 2022
In article 2106118, Kuan Sun and co-workers describe how a thin biguanide hydrochloride (BGCl) film is deposited at the SnO2/perovskite interface for simultaneous interfacial modification and crystallization control.
Zhuang Xiong +14 more
semanticscholar +1 more source
In article 2106118, Kuan Sun and co-workers describe how a thin biguanide hydrochloride (BGCl) film is deposited at the SnO2/perovskite interface for simultaneous interfacial modification and crystallization control.
Zhuang Xiong +14 more
semanticscholar +1 more source
, 2021
The utilization of nanotechnology for the design of pesticide formulations has enormous potential to enhance the efficiency of pesticides and reduce their adverse impacts on the environment.
Gang Tang +9 more
semanticscholar +1 more source
The utilization of nanotechnology for the design of pesticide formulations has enormous potential to enhance the efficiency of pesticides and reduce their adverse impacts on the environment.
Gang Tang +9 more
semanticscholar +1 more source
Antidiabetic Behavior of Biguanides
Journal of Pharmaceutical Sciences, 1983The existence of active electron pairs on some nitrogen atoms in phenformin hydrochloride is inferred from the presence of a hydrogen catalytic polarographic wave. This finding emphasizes the ability of biguanides to form hydrogen bridges with other molecular species such as amino acids and proteins, as well as to form coordination complexes with zinc ...
F. Vicente-Pedrós +2 more
openaire +3 more sources
Diabetes Care, 1992
The main biguanides, metformin and phenformin, were introduced in 1957 as oral glucose-lowering agents to treat non-insulin-dependent diabetes mellitus (NIDDM). Phenformin was withdrawn in many countries because of an association with lactic acidosis, but metformin does not have the same risk if appropriately prescribed. Metformin is now widely used as
openaire +3 more sources
The main biguanides, metformin and phenformin, were introduced in 1957 as oral glucose-lowering agents to treat non-insulin-dependent diabetes mellitus (NIDDM). Phenformin was withdrawn in many countries because of an association with lactic acidosis, but metformin does not have the same risk if appropriately prescribed. Metformin is now widely used as
openaire +3 more sources
IgE‐mediated chlorhexidine allergy—Cross‐reactivity with other biguanide disinfectants
Allergy. European Journal of Allergy and Clinical Immunology, 2020Chlorhexidine (CHX) is a widely utilized disinfectant that can cause IgE‐mediated urticaria/anaphylaxis. The cross‐reactivity of patients with IgE‐mediated CHX allergy with other disinfectants, which share structural similarities with CHX like ...
Nicole Mueller-Wirth +10 more
semanticscholar +1 more source
Demonstration of the mechanism of action of biguanides [PDF]
Acta Diabetologica Latina, 1973 Palmitic acid oxidation in rat diaphragm homogenate is depressed by biguanide concentrations that are still incapable of inhibiting oxidative phosphorylation. Glucose oxidation is not directly effected by the same biguanide concentrations: however, the inhibitory effect of palmitic acid on glucose oxidation is partly removed by biguanides.
MUNTONI S +3 more
openaire +2 more sources
Spectrophotometric (UV) investigation on biguanide and substituted biguanides
Tetrahedron, 1972Abstract Biguanide base and its monosalts have absorption maxima at 230 mμ which has been attributed to π-π* transition. The spectral effect on replacement of a carbon π centre by a heteroatom nitrogen centre is discussed and attempt has been made to predict the spectral shifts in biguanide base and normal salts due to the substitution heteronitrogen
openaire +2 more sources
, 2020
3590Background: IM156, a novel oral potent biguanide OXPHOS inhibitor of Protein Complex 1 (PC1) of the mitochondrial electron transport chain, causes AMPK phosphorylation, the downstream effects o...
S. Rha +14 more
semanticscholar +1 more source
3590Background: IM156, a novel oral potent biguanide OXPHOS inhibitor of Protein Complex 1 (PC1) of the mitochondrial electron transport chain, causes AMPK phosphorylation, the downstream effects o...
S. Rha +14 more
semanticscholar +1 more source
Specific Inhibition of Gluconeogenesis by Biguanides [PDF]
Nature, 1967 POSSIBLE schemes for the mechanism of the hypoglycaemic action of biguanides have raised considerable controversy in recent years. The possibility that these drugs may act through inhibition of oxidative phosphorylation, which may increase the glucose uptake of peripheral tissues1, has been frequently emphasized2–5, but experiments on the kinetics of ...
H. Clauser +2 more
openaire +2 more sources
1996
The use of biguanides as oral antidiabetic agents has elicited considerable problems due to their lack of sufficient tolerability. The first derivative, phenylethylbiguanide (phenformin), was given marketing approval in the United States in 1957. Due to the serious side effects, however, the compound was withdrawn from the market in the United States ...
W. Rebel +3 more
openaire +2 more sources
The use of biguanides as oral antidiabetic agents has elicited considerable problems due to their lack of sufficient tolerability. The first derivative, phenylethylbiguanide (phenformin), was given marketing approval in the United States in 1957. Due to the serious side effects, however, the compound was withdrawn from the market in the United States ...
W. Rebel +3 more
openaire +2 more sources